Annual Non Current Assets
$170.44 M
-$13.28 M-7.23%
December 31, 2023
Summary
- As of March 1, 2025, KYMR annual long term assets is $170.44 million, with the most recent change of -$13.28 million (-7.23%) on December 31, 2023.
- During the last 3 years, KYMR annual non current assets has fallen by -$14.39 million (-7.79%).
- KYMR annual non current assets is now -7.79% below its all-time high of $184.84 million, reached on December 31, 2020.
Performance
KYMR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$466.13 M
+$165.51 M+55.06%
September 30, 2024
Summary
- As of March 1, 2025, KYMR quarterly long term assets is $466.13 million, with the most recent change of +$165.51 million (+55.06%) on September 30, 2024.
- Over the past year, KYMR quarterly non current assets has increased by +$295.69 million (+173.48%).
- KYMR quarterly non current assets is now at all-time high.
Performance
KYMR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
KYMR Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | +173.5% |
| 3 y3 years | -7.8% | +173.5% |
| 5 y5 years | +6882.5% | +173.5% |
KYMR Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.2% | +10.2% | at high | +286.3% |
| 5 y | 5-year | -7.8% | +614.4% | at high | +1943.7% |
| alltime | all time | -7.8% | +6882.5% | at high | +1943.7% |
Kymera Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $466.13 M(+55.1%) |
| Jun 2024 | - | $300.61 M(-9.2%) |
| Mar 2024 | - | $331.00 M(+94.2%) |
| Dec 2023 | $405.32 M(-3.4%) | $170.44 M(-3.5%) |
| Sep 2023 | - | $176.68 M(-10.1%) |
| Jun 2023 | - | $196.54 M(-2.9%) |
| Mar 2023 | - | $202.35 M(+10.1%) |
| Dec 2022 | $419.42 M | $183.72 M(+27.2%) |
| Sep 2022 | - | $144.45 M(+19.7%) |
| Jun 2022 | - | $120.65 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $131.68 M(-14.8%) |
| Dec 2021 | $451.27 M(+49.3%) | $154.63 M(+56.6%) |
| Sep 2021 | - | $98.72 M(+41.9%) |
| Jun 2021 | - | $69.58 M(-43.8%) |
| Mar 2021 | - | $123.76 M(-33.0%) |
| Dec 2020 | $302.34 M(+225.6%) | $184.84 M(-12.0%) |
| Sep 2020 | - | $210.00 M(+820.7%) |
| Jun 2020 | - | $22.81 M(-4.4%) |
| Dec 2019 | $92.84 M(+122.2%) | $23.86 M |
| Dec 2018 | $41.79 M | - |
FAQ
- What is Kymera Therapeutics annual long term assets?
- What is the all time high annual non current assets for Kymera Therapeutics?
- What is Kymera Therapeutics annual non current assets year-on-year change?
- What is Kymera Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly non current assets year-on-year change?
What is Kymera Therapeutics annual long term assets?
The current annual non current assets of KYMR is $170.44 M
What is the all time high annual non current assets for Kymera Therapeutics?
Kymera Therapeutics all-time high annual long term assets is $184.84 M
What is Kymera Therapeutics annual non current assets year-on-year change?
Over the past year, KYMR annual long term assets has changed by -$13.28 M (-7.23%)
What is Kymera Therapeutics quarterly long term assets?
The current quarterly non current assets of KYMR is $466.13 M
What is the all time high quarterly non current assets for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly long term assets is $466.13 M
What is Kymera Therapeutics quarterly non current assets year-on-year change?
Over the past year, KYMR quarterly long term assets has changed by +$295.69 M (+173.48%)